product summary
Loading...
company name :
MyBioSource
product type :
protein
product name :
Recombinant Human Glycophorin-A
catalog :
MBS960329
quantity :
0.05 mg (E-Coli)
price :
180 USD
more info or order :
product information
catalog number :
MBS960329
products type :
Recombinant Protein
products full name :
Recombinant Human Glycophorin-A
products short name :
Glycophorin-A
products name syn :
MN sialoglycoprotein; PAS-2Sialoglycoprotein alpha; CD235a
other names :
glycophorin-A isoform 3; Glycophorin-A; glycophorin-A; glycophorin A (MNS blood group); MN sialoglycoprotein; PAS-2; Sialoglycoprotein alpha; CD_antigen: CD235a
products gene name :
GYPA
products gene name syn :
GPA
other gene names :
GYPA; GYPA; MN; GPA; MNS; GPSAT; PAS-2; CD235a; GPErik; HGpMiV; HGpMiXI; HGpSta(C); GPA
uniprot entry name :
GLPA_HUMAN
host :
E Coli or Yeast or Baculovirus or Mammalian Cell
sequence positions :
20-91, Partial,Provide the complete extracellular
sequence length :
91
sequence :
SSTTGVAMHTSTSSSVTKSYISSQTNDTHKRDTYAATPR
AHEVSEISVRTVYPPEEETGERVQLAHHFSEPE
purity :
Greater than 90% as determined by SDS-PAGE.
form :
Liquid containing glycerol; lyophilization may be available upon request.
storage stability :
Store at -20 degree C, for extended storage, conserve at -20 degree C or -80 degree C.
products categories :
Cardiovascular
products description :
Glycophorin A is the major intrinsic membrane protein of the erythrocyte. The N-terminal glycosylated segment, which lies outside the erythrocyte membrane, has MN blood group receptors. Appears to be important for the function of SLC4A1 and is required for high activity of SLC4A1. May be involved in translocation of SLC4A1 to the plasma membrane. Is a receptor for influenza virus. Is a receptor for Plasmodium falciparum erythrocyte-binding antigen 175 (EBA-175); binding of EBA-175 is dependent on sialic acid residues of the O-linked glycans. Appears to be a receptor for Hepatitis A virus (HAV).
products references :
Isolation and characterization of human glycophorin A cDNA clones by a synthetic oligonucleotide approach nucleotide sequence and mRNA structure.Siebert P.D., Fukuda M.Proc. Natl. Acad. Sci. U.S.A. 83:1665-1669(1986) Isolation of cDNA clones for human erythrocyte membrane sialoglycoproteins alpha and delta.Tate C.G., Tanner M.J.A.Biochem. J. 254:743-750(1988) Structural organization of glycophorin A and B genes glycophorin B gene evolved by homologous recombination at Alu repeat sequences.Kudo S., Fukuda M.Proc. Natl. Acad. Sci. U.S.A. 86:4619-4623(1989) The mechanism of production of multiple mRNAs for human glycophorin A.Jawad K., Burness T.H.Nucleic Acids Res. 18:5829-5836(1990) Characterization of glycophorin A transcripts control by the common erythroid-specific promoter and alternative usage of different polyadenylation signals.Kudo S., Onda M., Fukuda M.J. Biochem. 116:183-192(1994) Extensive alternative splicing of glycophorins in Southeast Asian populations.Hsu K., Huang S.-Y., Chi N., Lin M. Complete sequencing and characterization of 21,243 full-length human cDNAs.Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.Nat. Genet. 36:40-45(2004) Generation and annotation of the DNA sequences of human chromosomes 2 and 4.Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K., McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C., Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S., Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H., Wilson R.K.Nature 434:724-731(2005) Molecular biological study of the structure and expression of human glycophorin A.Siebert P.D., Fukuda M.Rev. Fr. Transfus. Immunohematol. 29:251-266(1986) Amino-acid sequence and oligosaccharide attachment sites of human erythrocyte glycophorin.Tomita M., Marchesi V.T.Proc. Natl. Acad. Sci. U.S.A. 72:2964-2968(1975) Furthmayr H., Galardy R., Tomita M., Marchesi V.T.Submitted (JUN-1977) to the PIR data bankCharacterization of cDNA clones for human glycophorin A. Use for gene localization and for analysis of normal of glycophorin-A-deficient (Finnish type) genomic DNA.Rahuel C., London J., D'Auriol L., Mattei M.-G., Tournamille C., Skrzynia C., Lebouc Y., Galibert F., Cartron J.-P.Eur. J. Biochem. 172:147-153(1988) Mg and Mc mutations within the amino-terminal region of glycophorin A.Furthmayr H., Metaxas M.N., Metaxas-Buhler M.Proc. Natl. Acad. Sci. U.S.A. 78:631-635(1981) Amino acid and carbohydrate structural variants of glycoprotein products (M-N glycoproteins) of the M-N allelic locus.Blumenfeld O.O., Adamany A.M., Puglia K.V.Proc. Natl. Acad. Sci. U.S.A. 78:747-751(1981) Structural studies on human erythrocyte glycoproteins. Alkali-labile oligosaccharides.Thomas D.B., Winzler R.J.J. Biol. Chem. 244:5943-5946(1969) Erythrocytes deficiency in glycophorin resist invasion by the malarial parasite Plasmodium falciparum.Pasvol G., Wainscoat J.S., Weatherall D.J.Nature 297:64-66(1982) Structures of novel sialylated O-linked oligosaccharides isolated from human erythrocyte glycophorins.Fukuda M., Lauffenburger M., Sasaki H., Rogers M.E., Dell A.J. Biol. Chem. 262:11952-11957(1987) The glycophorin A transmembrane domain dimer sequence-specific propensity for a right-handed supercoil of helices.Treutlein H.R., Lemmon M.A., Engelman D.M., Brunger A.T.Biochemistry 31:12726-12732(1992) Glycosylation sites identified by solid-phase Edman degradation O-linked glycosylation motifs on human glycophorin A.Pisano A., Redmond J.W., Williams K.L., Gooley A.A.Glycobiology 3:429-435(1993) Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum.Sim B.K., Chitnis C.E., Wasniowska K., Hadley T.J., Miller L.H.Science 264:1941-1944(1994) Identification of blood group A and B antigens in human glycophorin.Podbielska M., Krotkiewski H.Arch. Immunol. Ther. Exp. 48:211-221(2000) Red-cell glycophorin A-band 3 interactions associated with the movement of band 3 to the cell surface.Young M.T., Beckmann R., Toye A.M., Tanner M.J.Biochem. J. 350:53-60(2000) Glycophorin A dimerization and band 3 interaction during erythroid membrane biogenesis in vivo studies in human glycophorin A transgenic mice.Auffray I., Marfatia S., de Jong K., Lee G., Huang C.H., Paszty C., Tanner M.J., Mohandas N., Chasis J.A.Blood 97:2872-2878(2001) In vivo detection of hetero-association of glycophorin-A and its mutants within the membrane.Gerber D., Shai Y.J. Biol. Chem. 276:31229-31232(2001) Distinct regions of human glycophorin A enhance human red cell anion exchanger (band 3; AE1) transport function and surface trafficking.Young M.T., Tanner M.J.J. Biol. Chem. 278:32954-32961(2003) The blood group system.Reid M.E., Christine Lomas-Francis C.(In) Reid M.E., Christine Lomas-Francis C. (eds.) ;The blood group antigen factsbook, pp.29-104, Academic Press, Oxford (2004) ABH blood group antigens in O-glycans of human glycophorin A.Podbielska M., Fredriksson S.A., Nilsson B., Lisowska E., Krotkiewski H.Arch. Biochem. Biophys. 429:145-153(2004) Altered structure and anion transport properties of band 3 (AE1, SLC4A1) in human red cells lacking glycophorin A.Bruce L.J., Pan R.J., Cope D.L., Uchikawa M., Gunn R.B., Cherry R.J., Tanner M.J.J. Biol. Chem. 279:2414-2420(2004) Capsid region involved in hepatitis A virus binding to glycophorin A of the erythrocyte membrane.Sanchez G., Aragones L., Costafreda M.I., Ribes E., Bosch A., Pinto R.M.J. Virol. 78:9807-9813(2004) Hsa, an adhesin of Streptococcus gordonii DL1, binds to alpha2-3-linked sialic acid on glycophorin A of the erythrocyte membrane.Yajima A., Urano-Tashiro Y., Shimazu K., Takashima E., Takahashi Y., Konishi K.Microbiol. Immunol. 52:69-77(2008) Interaction of anion exchanger 1 and glycophorin A in human erythroleukaemic K562 cells.Pang A.J., Reithmeier R.A.Biochem. J. 421:345-356(2009) An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., Ye M., Zou H.J. Proteomics 96:253-262(2014) One- and two-dimensional NMR studies of the N-terminal portion of glycophorin A at 11.7 Tesla.Dill K., Hu S.H., Berman E., Pavia A.A., Lacombe J.M.J. Protein Chem. 9:129-136(1990) A transmembrane helix dimer structure and implications.Mackenzie K.R., Prestegard J.H., Engelman D.M.Science 276:131-133(1997) Improved prediction for the structure of the dimeric transmembrane domain of glycophorin A obtained through global searching.Adams P.D., Engelman D.M., Bruenger A.T.3.3.CO;2-O>Proteins 26:257-261(1996) Molecular basis for the human erythrocyte glycophorin specifying the Miltenberger class I (MiI) phenotype.Huang C.-H., Spruell P., Moulds J.J., Blumenfeld O.O.Blood 80:257-263(1992) Molecular analysis of human glycophorin MiIX gene shows a silent segment transfer and untemplated mutation resulting from gene conversion via sequence repeats.Huang C.H., Skov F., Daniels G., Tippett P., Blumenfeld O.O.Blood 80:2379-2387(1992) Alteration of splice site selection by an exon mutation in the human glycophorin A gene.Huang C.H., Reid M., Daniels G., Blumenfeld O.O.J. Biol. Chem. 268:25902-25908(1993) Glycophorin A mutation Ala65 --> Pro gives rise to a novel pair of MNS alleles ENEP (MNS39) and HAG (MNS41) and altered Wrb expression direct evidence for GPA/band 3 interaction necessary for normal Wrb expression.Poole J., Banks J., Bruce L.J., Ring S.M., Levene C., Stern H., Overbeeke M.A., Tanner M.J.Transfus. Med. 9:167-174(1999) The low-frequency MNS blood group antigens Ny(a) (MNS18) and Os(a) (MNS38) are associated with GPA amino acid substitutions.Daniels G.L., Bruce L.J., Mawby W.J., Green C.A., Petty A., Okubo Y., Kornstad L., Tanner M.J.Transfusion 40:555-559(2000) The MNS blood group antigens, Vr (MNS12) and Mt(a) (MNS14) , each arise from an amino acid substitution on glycophorin A.Storry J.R., Coghlan G., Poole J., Figueroa D., Reid M.E.Vox Sang. 78:52-56(2000) +Additional computationally mapped references. p>Provides general information on the entry.
ncbi gi num :
815891063
ncbi acc num :
NP_001295119.1
ncbi gb acc num :
NM_001308190.1
uniprot acc num :
P02724
ncbi mol weight :
35.4kD
ncbi pathways :
Hematopoietic Cell Lineage Pathway (83078); Hematopoietic Cell Lineage Pathway (489); Malaria Pathway (152665); Malaria Pathway (152657)
ncbi summary :
Glycophorins A (GYPA) and B (GYPB) are major sialoglycoproteins of the human erythrocyte membrane which bear the antigenic determinants for the MN and Ss blood groups. In addition to the M or N and S or s antigens that commonly occur in all populations, about 40 related variant phenotypes have been identified. These variants include all the variants of the Miltenberger complex and several isoforms of Sta, as well as Dantu, Sat, He, Mg, and deletion variants Ena, S-s-U- and Mk. Most of the variants are the result of gene recombinations between GYPA and GYPB. [provided by RefSeq, Jul 2008]
size1 :
0.05 mg (E-Coli)
price1 :
180 USD
size2 :
0.05 mg (Yeast)
price2 :
260
size3 :
0.2 mg (E-Coli)
price3 :
490
size4 :
0.2 mg (Yeast)
price4 :
600
size5 :
0.5 mg (E-Coli)
price5 :
715
more info or order :
company information
MyBioSource
P.O. Box 153308
San Diego, CA 92195-3308
sales@mybiosource.com
https://www.mybiosource.com
1-888-627-0165
headquarters: USA
MyBioSource, LLC was orginally founded in Vancouver by three enthusiastic scientists who are passionate about providing the world with the best reagents available. Together, they form a company with a big vision known as MyBioSource. MyBioSource is now located in San Diego, California, USA.

"MyBioSource's number 1 vision is to be the world's number 1 quality reagents provider."

Our goal is to provide researchers, scientists and customers alike with a one-stop-shop for all of their reagents needs, whether it is monoclonal antibody, polyclonal antibody, recombinant protein, peptide, etc...

"MyBioSource offers the best products at unbeatable prices."

Please spend a few minutes to browse our online catalogs and see the wide range of products available. We ship our products through our shipping/distribution facility in San Diego, California, USA.

Would you like to receive email and e-newsletter from MyBioSource about new products, special offers and events? Please click here to join our Mailing List!